Related Experiment Video
Updated: Jun 6, 2026

08:49
A 3D Organotypic Melanoma Spheroid Skin Model
Published on: May 18, 2018
Primary oesophageal malignant melanoma.
David A Westwood1, Jeffrey B Macemon, Grant N Coulter
1Department of General Surgery, Christchurch Public Hospital, Private Bag 4710, Christchurch 8140, New Zealand. d.westwood@doctors.net.uk
Summary
Primary oesophageal malignant melanoma, though rare and aggressive, can be treated with Ivor-Lewis oesophagogastrectomy. This surgical approach offers potential for long-term survival in selected patients.
Area of Science:
- Gastroenterology
- Surgical Oncology
- Oncology
Background:
- Primary oesophageal malignant melanoma is an exceedingly rare and aggressive malignancy.
- The prognosis for this condition is typically poor, often considered dismal.
- Radical resection offers a possibility for long-term survival in carefully selected cases.
Observation:
- This report details two cases of primary oesophageal malignant melanoma.
- Both patients underwent surgical treatment using the Ivor-Lewis oesophagogastrectomy procedure.
- A comprehensive review of existing literature on this rare condition was also performed.
Findings:
- The Ivor-Lewis oesophagogastrectomy was successfully employed in the management of these two rare cases.
- The literature review provides context for these surgical outcomes within the broader understanding of oesophageal melanoma.
- These cases contribute to the limited data available on effective treatments for primary oesophageal malignant melanoma.
Implications:
- Surgical resection, specifically the Ivor-Lewis oesophagogastrectomy, may be a viable option for select patients with primary oesophageal malignant melanoma.
- Further research and case reporting are crucial for improving the understanding and management of this rare cancer.
- This approach highlights the importance of surgical intervention in potentially improving outcomes for aggressive, rare tumours.
Related Concept Videos
Skin Cancer
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Barrett Esophagus-I: Introduction
Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Barrett Esophagus-II: Clinical Manifestations and Management
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure entails...

